Zacks.com on MSN16h
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
Gilead Sciences (GILD) ended the recent trading session at $85.83, demonstrating a +0.91% swing from the preceding day's closing price. This move outpaced the S&P 500's daily loss of 0.76%. Meanwhile, ...
bovnews1d
The Gilead Sciences, Inc. Rollercoaster: What’s Behind the Latest GILD Stock Fluctuation?
On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...
Highlands' Ivan Hilton science building closed through end of semester following chemical spill
New Mexico Highlands University's Ivan Hilton Science and Technology Building will remain closed to students through the end of the semester, following incident last month in which a hazardous ...
MarketWatch4d
Gilead Sciences Inc. stock rises Friday, still underperforms market
Shares of Gilead Sciences Inc. GILD inched 0.33% higher to $84.95 Friday, on what proved to be an all-around great trading ...
Morgan Stanley Remains a Hold on Gilead Sciences (GILD)
Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Gilead Sciences (GILD – Research Report) today and set a price target ...
Hosted on MSN4d
Gilead's HIV Prevention Treatment Lenacapavir Shows Potential
Gilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...